Showing results (251-260 of 267) with videos related to
Sort By:
Pageof 27
Infection & Chemotherapy|April 4, 2025
Characteristics and Prevalence of Sequelae after COVID-19: A Longitudinal Cohort StudySe Ju Lee, Yae Jee Baek, Su Hwan Lee, et al.Nature Communications|August 25, 2019
Development of a SFTSV DNA vaccine that confers complete protection against lethal infection in ferretsJeong-Eun Kwak, Young-Il Kim, Su-Jin Park, et al.Immunity & Ageing : I & A|July 31, 2024
Overcoming the age-dependent SARS-CoV-2 vaccine response through hybrid immunity: analysis of humoral and cellular immunity with mass cytometry profilingZayakhuu Gerelkhuu, Sehee Park, Kyoung Hwa Lee, et al.Journal of Medical Virology|December 23, 2023
Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variantsBeomki Lee, Jae-Hoon Ko, Yong Chan Kim, et al.Microbiology Spectrum|October 17, 2022
Estimation of SARS-CoV-2 Neutralizing Activity and Protective Immunity in Different Vaccine Types Using Three Surrogate Virus Neutralization Test Assays and Two Semiquantitative Binding Assays Targeting the Receptor-Binding DomainBeomki Lee, Jae-Hoon Ko, Kyoung Hwa Lee, et al.Vaccine|March 14, 2022
Persistent serotype 3 and 19A invasive pneumococcal diseases in adults in vaccine era: Serotype-dependent difference in ceftriaxone susceptibilityJin Gu Yoon, A-Yeung Jang, Min Ja Kim, et al.Vaccine|July 31, 2018
Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014Ji Yun Noh, Won Suk Choi, Joon Young Song, et al.Emerging Microbes & Infections|March 15, 2018
Comparison of the pathogenic potential of highly pathogenic avian influenza (HPAI) H5N6, and H5N8 viruses isolated in South Korea during the 2016-2017 winter seasonHyeok-Il Kwon, Eun-Ha Kim, Young-Il Kim, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 22, 2022
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicitySeongman Bae, Jae-Hoon Ko, Ju-Yeon Choi, et al.Infection & Chemotherapy|July 4, 2020
The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic DiseaseYu Bin Seo, Su Jin Moon, Chan Hong Jeon, et al.Pageof 27